
No data
No data
No data
| CAS Number | 968-81-0 |
| Catalog Number | AG005SIZ(AGN-PC-0JK633) |
| Chemical Name | Acetohexamide |
| EC Number | 213-530-4 |
| IUPAC Name | 1-(4-acetylphenyl)sulfonyl-3-cyclohexylurea |
| InChI | InChI=1S/C15H20N2O4S/c1-11(18)12-7-9-14(10-8-12)22(20,21)17-15(19)16-13-5-3-2-4-6-13/h7-10,13H,2-6H2,1H3,(H2,16,17,19) |
| InChI Key | VGZSUPCWNCWDAN-UHFFFAOYSA-N |
| MDL Number | MFCD00072156 |
| Molecular Formula | C15H20N2O4S |
| Molecular Weight | 324.3953 |
| NSC Number | 759128 |
| SMILES | O=C(NS(=O)(=O)c1ccc(cc1)C(=O)C)NC1CCCCC1 |
| UNII | QGC8W08I6I |
| Synonyms | Acetohexamide,
Dimelor,
Dymelor,
Gamadiabet,
acetohexamide,
968-81-0,
Dymelor,
Acetohexamid,
Gamadiabet,
Dimelor,
Hypoglicil,
Metaglucina,
Tsiklamid,
Dimelin,
Minoral,
Ordimel,
Acetohexamida,
Acetohexamidum,
N-(p-Acetylphenylsulfonyl)-N'-cyclohexylurea,
Acetohexamidum [INN-Latin],
Acetohexamida [INN-Spanish],
1-(4-acetylphenyl)sulfonyl-3-cyclohexylurea,
1-((p-Acetylphenyl)sulfonyl)-3-cyclohexylurea,
CCRIS 4,
NCI-C03247,
UNII-QGC8W08I6I,
1-(p-Acetylbenzenesulfonyl)-3-cyclohexylurea,
U-14812,
HSDB 3280,
4-Acetyl-N-((cyclohexylamino)carbonyl)benzenesulfonamide,
4-Acetyl-N-[(cyclohexylamino)carbonyl]benzenesulfonamide,
Benzenesulfonamide, 4-acetyl-N-[(cyclohexylamino)carbonyl]-,
EINECS 213-530-4,
U 14812,
BRN 2225115,
QGC8W08I6I,
Benzenesulfonamide, 4-acetyl-N-((cyclohexylamino)carbonyl)-,
3-(4-acetylbenzenesulfonyl)-1-cyclohexylurea,
C15H20N2O4S,
CHEBI:28052,
N-(p-Acetylbenzenesulfonyl)-N'-cyclohexylurea,
4-Acetyl-N-[(cyclohexylamino)-carbonyl]benzenesulfonamide,
DSSTox_CID_7,
NCGC00015014-05,
CAS-968-81-0,
1-[(p-Acetylphenyl)sulfonyl]-3-cyclohexylurea,
DSSTox_RID_75319,
4-acetyl-N-(cyclohexylcarbamoyl)benzenesulfonamide,
DSSTox_GSID_20007,
Urea, 1-((p-acetylphenyl)sulfonyl)-3-cyclohexyl-,
Urea, 1-[(p-acetylphenyl)sulfonyl]-3-cyclohexyl-,
ord imel,
Dymelor (TN),
dimelin (antidiabetic),
SR-01000075539,
Acetohexamide [USAN:INN:BAN:JAN],
Prestwick_3,
Acetohexamide [USAN),
Acetohexamide [USAN:USP:INN:BAN:JAN],
Lopac-A-178,
AC1L1COE,
3-cyclohexyl-1-(p-acetylphenylsulfonyl)urea,
Prestwick0_000055,
Prestwick1_000055,
Prestwick2_000055,
Prestwick3_000055,
A-178,
CHEMBL1589,
Lopac0_000088,
SCHEMBL37620,
BSPBio_000209,
MLS002154186,
SPBio_002130,
BPBio1_000231,
GTPL6793,
DTXSID7020007,
CTK8F7520,
4-acetyl-N-((cyclohexylamino)carbonyl)benzenesulf onamide,
Acetohexamide (JP17/USP/INN),
Acetohexamide, analytical standard,
VGZSUPCWNCWDAN-UHFFFAOYSA-N,
HMS1568K11,
HMS2093H21,
HMS2095K11,
HMS2236M07,
HMS3260A18,
HMS3372B02,
HMS3712K11,
Pharmakon1600-01505425,
HY-B0881,
KS-00001F9N,
Tox21_110067,
Tox21_202022,
Tox21_302735,
Tox21_500088,
MFCD00072156,
NSC759128,
ZINC18067894,
AKOS015916290,
Tox21_110067_1,
API0002381,
CCG-204183,
DB00414,
LP00088,
LS-2019,
MCULE-3744173137,
NSC-759128,
VZ31185,
NCGC00015014-01,
NCGC00015014-02,
NCGC00015014-03,
NCGC00015014-04,
NCGC00015014-06,
NCGC00015014-07,
NCGC00015014-08,
NCGC00015014-11,
NCGC00016555-01,
NCGC00091230-01,
NCGC00091230-02,
NCGC00091230-03,
NCGC00091230-04,
NCGC00256467-01,
NCGC00259571-01,
NCGC00260773-01,
CC-23668,
SC-70790,
SMR001233477,
SBI-0050076.P002,
EU-0100088,
FT-0661053,
1-(4-acetylbenzenesulfonyl)-3-cyclohexylurea,
1-(4-acetylphenyl)sulfonyl-3-cyclohexyl-urea,
1-cyclohexyl-3-(4-ethanoylphenyl)sulfonyl-urea,
C06806,
D00219,
1-[(4-acetylbenzene)sulfonyl]-3-cyclohexylurea,
A845651,
C-19808,
SR-01000075539-1,
SR-01000075539-3,
SR-01000075539-6,
4-acetyl-N-(cyclohexylcarbamoyl)benzene-1-sulfonamide,
BRD-K52960356-001-03-1,
BRD-K52960356-001-06-4,
I14-51513,
Z1558572527,
4-Acetyl-N-[(cyclohexylamino)- carbonyl]benzenesulfonamide,
1-Acetyl-4-(([(cyclohexylamino)carbonyl]amino)sulfonyl)benzene #,
Acetohexamide, United States Pharmacopeia (USP) Reference Standard,
1-[(4-acetylbenzene)sulfonyl]-3-cyclohexylurea 4-acetyl-N-(cyclohexylcarbamoyl)benzenesulfonamide,
Cyclamide,
Acetohexamide Lilly Brand,
Acetohexamide Salvat Brand,
D07WFK,
Lilly Brand of Acetohexamide,
Salvat Brand of Acetohexamide,
Acetohexamide (JP15/USP/INN),
CID1989,
Acetohexamide [USAN:BAN:INN:JAN],
C15-H20-N2-O4-S,
CS-4336,
D000092,
|
| Complexity | 498 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 324.114g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 22 |
| Hydrogen Bond Acceptor Count | 4 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 324.395g/mol |
| Monoisotopic Mass | 324.114g/mol |
| Rotatable Bond Count | 4 |
| Topological Polar Surface Area | 101A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 2.4 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H315-H319-H335 |
| Packing Group | |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

